Epclusa (sofosbuvir/velpatasvir) is a crucial medication for the treatment of chronic hepatitis C. Proper purchasing methods and the ability to identify genuine vs. counterfeit products are of great importance to patients’ treatment efficacy and medication safety.

How to Purchase Epclusa (Sofosbuvir/Velpatasvir)

Overseas Purchase

Patients may choose to consult and purchase Epclusa at hospital pharmacies or licensed drugstores in countries or regions where the medication has been launched.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.

Purchase via Medical Service Institutions

Patients may consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions usually provide legal import channels and offer professional consultation and guidance.

Precautions for Purchasing Epclusa (Sofosbuvir/Velpatasvir)

Strictly Follow Doctor’s Instructions

The use of Epclusa must strictly comply with the doctor’s instructions, including dosage and treatment course.

According to drug information, the recommended dosage for adults is one tablet taken orally once daily (containing 400 mg sofosbuvir and 100 mg velpatasvir).

Patients should not adjust the medication regimen or discontinue treatment on their own; any changes to medication must be made under the guidance of a doctor.

Pay Attention to Drug Interactions

When purchasing and using Epclusa, patients need to inform doctors in detail about other medications they are taking, as concurrent use of Epclusa with certain drugs may cause adverse reactions.

It is particularly important to note that the combined use of Epclusa and amiodarone may lead to severe symptomatic bradycardia.

If a patient is taking amiodarone, they must inform the doctor, who will assess the risks and determine the treatment plan.

Focus on Medication for Special Populations

For pediatric patients, the dosage of Epclusa needs to be adjusted based on body weight.

According to drug information, the recommended dosage for pediatric patients aged 3 years and older is based on body weight; specific medication guidelines should refer to the weight table in the complete prescribing information.

Necessary Examinations Before Purchase

Before starting Epclusa treatment, doctors will conduct a hepatitis B virus test on the patient.

Methods to Identify Genuine Epclusa (Sofosbuvir/Velpatasvir)

Packaging Inspection

The packaging of genuine Epclusa should be intact, clean, and clearly printed.

Epclusa is available in two dosage forms: tablets and oral granules, with four specifications: 400mg/100mg tablets, 200mg/50mg tablets, 200mg/50mg oral granules, and 150mg/37.5mg oral granules.

Patients should carefully verify the relevant information on the packaging, including the drug name, batch number, and expiration date.

Special attention should be paid to checking whether the tamper-evident seal on the packaging is intact.

Drug Appearance Identification

Each dosage form of Epclusa has its specific appearance characteristics.

The 400mg/100mg tablets are pink, diamond-shaped, film-coated tablets, engraved with "GSI" on one side and "7916" on the other side.